Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PIRAMAL PHARMA LIMITED Capital/Financing Update 2023

Aug 3, 2023

59525_rns_2023-08-03_62fc556a-86b1-4225-95f6-dcfa9540ae8f.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [145 x 60] intentionally omitted <==

A. Statement of utilization of issue proceeds:

Name of theIssuer ISIN Mode of FundRaising(Publicissues/Privateplacement) Type ofinstrument Date ofraisingfunds AmountRaised(Rs. incrores) Fundsutilized(Rs. incrores) Anydeviation(Yes / No) If 8 is Yes,then specifythe purposeof for whichthe fundswere utilized Remarks,if any
1 2 3 4 5 6 7 8 9 10
Piramal PharmaLimited INE0DK507034 PrivatePlacement Non-ConvertibleDebentures 03.10.2022 100 100 No - -
Total 100 100

Piramal Pharma Limited

CIN: U24297MH2020PLC338592

Registered Office: Gr. Flr. Piramal Ananta, Agastya Corporate Park, Opp Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070 India T +91 22 3802 3000 / 4000

piramal.com

==> picture [145 x 60] intentionally omitted <==

B. Statement of deviation / variation in utilization of funds raised

Particulars Remarks Remarks Remarks Remarks Remarks Remarks
Name of listed entity Piramal Pharma Limited
Mode of fund raising Private Placement
Type of instrument Non-ConvertibleDebentures
Date of raising funds As mentioned above in point no. A
Amount raised (Rs. in crores)
Report filed for quarter ended 30.06.2023
Is there a deviation / variation in use of funds raised? No
Whether any approval is required to vary the objects ofthe issue stated in the prospectus/ offer document? No
If yes, details of the approval so required? N.A.
Date of approval
Explanation for the deviation / variation
Comments of the audit committee after review
Comments of the auditors, if any
Objects for which funds have been raised and where there has been a deviation / variation, in the following table
Original object Modifiedobject, ifany Originalallocation Modifiedallocation,if any Fundsutilized Amount of deviation/variationfor the quarter according toapplicable object (in Rs.Crore and in %) Remarks,if any
N.A., since there was no deviation in the utilization of funds from the objects stated in the offer documents
Deviation could mean:a) Deviation in the objects or purposes for which the funds have been raised.b) Deviation in the amount of funds actuallyutilized as against what was originallydisclosed.

Piramal Pharma Limited

CIN: U24297MH2020PLC338592

Registered Office: Gr. Flr. Piramal Ananta, Agastya Corporate Park, Opp Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070 India T +91 22 3802 3000 / 4000

piramal.com